1. Home
  2. ARBE vs ICCC Comparison

ARBE vs ICCC Comparison

Compare ARBE & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbe Robotics Ltd.

ARBE

Arbe Robotics Ltd.

N/A

Current Price

$0.66

Market Cap

79.1M

Sector

Technology

ML Signal

N/A

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$9.94

Market Cap

93.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARBE
ICCC
Founded
2015
1982
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
79.1M
93.1M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
ARBE
ICCC
Price
$0.66
$9.94
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$2.38
N/A
AVG Volume (30 Days)
959.3K
27.5K
Earning Date
05-19-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.85
EPS
N/A
0.41
Revenue
N/A
$26,493,169.00
Revenue This Year
$363.94
N/A
Revenue Next Year
$286.43
N/A
P/E Ratio
N/A
$24.44
Revenue Growth
N/A
51.64
52 Week Low
$0.55
$4.52
52 Week High
$2.88
$12.10

Technical Indicators

Market Signals
Indicator
ARBE
ICCC
Relative Strength Index (RSI) 40.83 42.02
Support Level $0.65 $9.36
Resistance Level $0.90 $10.75
Average True Range (ATR) 0.04 0.45
MACD -0.01 -0.07
Stochastic Oscillator 4.58 29.56

Price Performance

Historical Comparison
ARBE
ICCC

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, Hong Kong, USA, Israel, Switzerland, Italy, and others.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: